TrialBMJ open2014

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.

Pelle L Ishøy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.